Yoshimaru Yamamoto
Plus aucun poste en cours
Profil
Yoshimaru Yamamoto is a Director and General Manager of Bioenvision, Inc. Prior to joining Bioenvision, he was Senior Product Manager of Novo Nordisk Pharmaceuticals Industries, Inc. Mr. Yamamoto began his career with Morishita Pharmaceutical Co. Ltd.
Anciens postes connus de Yoshimaru Yamamoto
| Sociétés | Poste | Fin |
|---|---|---|
Bioenvision, Inc.
 Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 25/10/2007 |
Novo Nordisk Pharmaceutical Industries, Inc.
 Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Novo Nordisk Pharmaceutical Industries, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Clayton, NC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Bioenvision, Inc.
Bioenvision, Inc. Medical/Nursing ServicesHealth Services Bioenvision, Inc. engages in the acquisition, development, distribution, and marketing of compounds and technologies for the treatment of cancer. It also develops anti-infective technologies, which includes the OLIGON(R) technology. The company was founded by Christopher B. Wood on August 16, 1996 and is headquartered in New York, NY. | Health Services |
Novo Nordisk Pharmaceutical Industries, Inc.
Novo Nordisk Pharmaceutical Industries, Inc. Pharmaceuticals: MajorHealth Technology Part of Novo Nordisk A/S, Novo Nordisk Pharmaceutical Industries, Inc. is a company that manufactures pharmaceutical preparations. The company is based in Clayton, NC. | Health Technology |
